Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma
Martin Kaiser(Royal Marsden NHS Foundation Trust), Niels Weinhold(German Cancer Research Center), Andréa Capra, Jorge Acosta‐Reyes(Bristol-Myers Squibb (Switzerland)), Mario Boccadoro(University of Turin), Juan José Lahuerta(Research Institute Hospital 12 de Octubre), Jesús F. San Miguel(Clinica Universidad de Navarra), Alessandra Larocca(Cornell University), María‐Victoria Mateos(Hospital Clínico San Carlos), Francesca Gay(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Gordon Cook(University of Leeds), Marc‐Andrea Baertsch(German Cancer Research Center), Joan Bladé(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), David A. Cairns(BMW (Germany)), Anita K. Gandhi(Bristol-Myers Squibb (United States)), Pellegrino Musto(University of Bari Aldo Moro), Norma C. Gutiérrez(Universidad de Salamanca), Rick Zhang(Sanofi (United States)), Uta Bertsch(Heidelberg University), Kwee Yong(CRUK Lung Cancer Centre of Excellence), Marc S. Raab(Unknown), Sarah Brown(University of Leeds), Sandrine Macé(Sanofi (France)), Graham Jackson(Newcastle College), Rakesh Popat(University College London Hospitals NHS Foundation Trust), Cong Li(Tianjin Stomatological Hospital), Pieter Sonneveld(Erasmus MC Cancer Institute), K. Elias(Heidelberg University), Franck Dubin(Sanofi (France))
Cited by 17
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k